IP Verse

Innopharma Licensing competitive analysis

Explore the latest publications and patents granted to Innopharma Licensing, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Innopharma Licensing, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 30, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Innopharma Licensing
IPR2017-00905	Feb 17, 2017	INNOPHARMA LICENSING	ASTRAZENECA AB	Institution Denied
IPR2017-00904	Feb 17, 2017	INNOPHARMA LICENSING	ASTRAZENECA AB	Institution Denied
IPR2017-00900	Feb 17, 2017	INNOPHARMA LICENSING	ASTRAZENECA AB	Institution Denied
IPR2016-00091	Nov 2, 2015	INNOPHARMA LICENSING	SENJU PHARMACEUTICAL	Final Written Decision
IPR2016-00090	Nov 2, 2015	INNOPHARMA LICENSING	SENJU PHARMACEUTICAL	Final Written Decision
IPR2016-00089	Nov 2, 2015	INNOPHARMA LICENSING	SENJU PHARMACEUTICAL	Final Written Decision
IPR2015-00902	Mar 19, 2015	INNOPHARMA LICENSING	SENJU PHARMACEUTICAL	Final Written Decision

IP litigation analysis comparing Innopharma Licensing with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
INNOPHARMA LICENSING	-	-	7	-	Highly Aggressive
ASTRAZENECA AB	-	-	-	18	Non-Active
SENJU PHARMACEUTICAL	-	-	-	14	Non-Active